Literature DB >> 7698220

Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblasts.

P Atadja1, H Wong, C Veillete, K Riabowol.   

Abstract

Human cyclin D1 forms complexes with several Cdks, with proliferating cell nuclear antigen, and with a recently discovered 21-kDa inhibitor of Cdk activity. Substrates for cyclin D1/Cdks have not been identified in vivo, but it has been proposed that the D class of cyclins might play a role in regulating the activity of the retinoblastoma gene product p105Rb. Here we report that normal human diploid fibroblasts that endogenously or ectopically express high levels of cyclin D1 are unable to enter S phase in response to normally mitogenic stimuli. Fibroblasts that have reached the end of their in vitro life span (senescent cells) express five-fold higher levels of cyclin D1 protein than low-passage cells and individual cells in mass culture that fail to initiate DNA synthesis in response to serum addition have severalfold higher levels of this cyclin than proliferation-competent cells. These observations provide evidence that cyclin D1 is involved with the regulation of cell proliferation by more than one mechanism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7698220     DOI: 10.1006/excr.1995.1080

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  23 in total

1.  Silencing of the Menkes copper-transporting ATPase (Atp7a) gene increases cyclin D1 protein expression and impairs proliferation of rat intestinal epithelial (IEC-6) cells.

Authors:  Sukru Gulec; James F Collins
Journal:  J Trace Elem Med Biol       Date:  2014-08-04       Impact factor: 3.849

2.  Smurf2 up-regulation activates telomere-dependent senescence.

Authors:  Hong Zhang; Stanley N Cohen
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

3.  Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells.

Authors:  M Meyyappan; H Wong; C Hull; K T Riabowol
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

4.  Repression of cyclin D1 expression does not contribute to initiation or maintenance of cell transformation by adenovirus type 5 E1.

Authors:  O Kranenburg; P Keblusek; A J Van der Eb; A Zantema
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Knockdown of Rho-associated protein kinase 1 suppresses proliferation and invasion of glioma cells.

Authors:  Peng Zhang; Ying Lu; Xue You Liu; Yu Hua Zhou
Journal:  Tumour Biol       Date:  2014-09-30

6.  High-level Sp1 is Associated with Proliferation, Invasion, and Poor Prognosis in Astrocytoma.

Authors:  Yi-Ting Chen; Hung-Pei Tsai; Chun-Chieh Wu; Chiao-Yun Chen; Chee-Yin Chai; Aij-Lie Kwan
Journal:  Pathol Oncol Res       Date:  2018-06-09       Impact factor: 3.201

7.  Knockdown of HMGB1 improves apoptosis and suppresses proliferation and invasion of glioma cells.

Authors:  Jing Zhang; Cang Liu; Ruiguang Hou
Journal:  Chin J Cancer Res       Date:  2014-12       Impact factor: 5.087

8.  γ-Tocotrienol prevents cell cycle arrest in aged human fibroblast cells through p16INK4a pathway.

Authors:  Azalina Zainuddin; Kien-Hui Chua; Jen-Kit Tan; Faizul Jaafar; Suzana Makpol
Journal:  J Physiol Biochem       Date:  2016-10-14       Impact factor: 4.158

9.  Nuclear accumulation of cyclin D1 following long-term fractionated exposures to low-dose ionizing radiation in normal human diploid cells.

Authors:  Tsutomu Shimura; Nobuyuki Hamada; Megumi Sasatani; Kenji Kamiya; Naoki Kunugita
Journal:  Cell Cycle       Date:  2014-02-14       Impact factor: 4.534

10.  Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence.

Authors:  Kensuke Kumamoto; Elisa A Spillare; Kaori Fujita; Izumi Horikawa; Taro Yamashita; Ettore Appella; Makoto Nagashima; Seiichi Takenoshita; Jun Yokota; Curtis C Harris
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.